Acadian Asset Management LLC Ikena Oncology, Inc. Transaction History
Acadian Asset Management LLC
- $28.7 Billion
- Q1 2024
A detailed history of Acadian Asset Management LLC transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 282,782 shares of IKNA stock, worth $460,934. This represents 0.0% of its overall portfolio holdings.
Number of Shares
282,782
Previous 21,722
1201.82%
Holding current value
$460,934
Previous $41,000
875.61%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IKNA
# of Institutions
60Shares Held
32MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$8.18 Million0.89% of portfolio
-
Bvf Inc San Francisco, CA4.77MShares$7.77 Million0.2% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.89MShares$6.34 Million1.46% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$5.77 Million0.11% of portfolio
-
Omega Fund Management, LLC Boston, MA2.25MShares$3.67 Million3.31% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $59.1M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...